Celebration of Life Events

“Celebration of Life” events are taking place at many hospitals across the country. Last week, celebrations were held at Orange Regional Medical Center in Middletown, New York; Eastland Memorial Hospital, Eastland, Texas; and, Weatherford Regional Medical Center, Weatherford, Texas. These events enable clinicians and staff to reconnect personally with patients.

celebrationoflife1At the Orange Regional Medical Center, Jonathan Schiller, Chief Operating Officer, introduced the event and Dr. Apurva Motivala reviewed the cardiology program and the passion that drives their staff to create wonderful recovery stories.

celebrationoflife2Eastland Memorial Hospital hosted a Celebration of Life luncheon, where Dr. Farhan Ali and Impella patient, Justin Redman, both spoke about the importance of ensuring that smaller, community hospitals are aware of the potential benefits of Protected PCI procedures that are being performed at other centers.

Another event at Weatherford Regional Medical Center offered members of the hospital and community the chance to see the recently updated Cardiac Services Department, including the state of the art cardiac catheterization laboratory.

Talk with your doctor to discuss what procedure is best for your medical condition.

Next Steps:

  1. Read more about the Protected PCI procedure
  2. Read more about the Celebration of Life at Weatherford Regional Medical Center
  3. Read more about the difference between PCI and Protected PCI
  4. See how the Impella 2.5 heart pump works
  5. Listen to more patient stories about the Impella heart pump
  6. Learn more about complex heart disease

About Impella

The Impella 2.5 system is a temporary (<6 hours) ventricular support device indicated for use during high risk percutaneous coronary interventions (PCI) performed in elective or urgent, hemodynamically stable patients with severe coronary artery disease and depressed left ventricular ejection fraction, when a heart team, including a cardiac surgeon, has determined high risk PCI is the appropriate therapeutic option. Use of the Impella 2.5 in these patients may prevent hemodynamic instability which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri- and post-procedural adverse events.

Protected PCI and use of the Impella 2.5 is not right for every patient. Patients may not be able to be treated with Impella if they have certain pre-existing conditions, which a cardiologist can determine, such as: severe narrowing of the heart valve, severe peripheral artery disease, clots in blood vessels, or a replacement heart valve or certain heart valve deficiencies. Additionally, use of Impella has been associated with risks, including, but not limited to valvular and vascular injury, bleeding, and limb ischemia in certain patients. Learn more about the Impella devices’ approved indications for use, as well as important safety and risk information at www.protectedpci.com/indications-use-safety-information/.